Tom Frohlich - Net Worth and Insider Trading

Tom Frohlich Net Worth

The estimated net worth of Tom Frohlich is at least $6 Million dollars as of 2024-05-14. Tom Frohlich is the COO of Chinook Therapeutics Inc and owns about 150,777 shares of Chinook Therapeutics Inc (KDNY) stock worth over $6 Million. Details can be seen in Tom Frohlich's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tom Frohlich has not made any transactions after 2023-02-10 and currently still holds the listed stock(s).

Transaction Summary of Tom Frohlich

To

Tom Frohlich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tom Frohlich owns 2 companies in total, including Aduro Biotech Inc (ADRO) , and Chinook Therapeutics Inc (KDNY) .

Click here to see the complete history of Tom Frohlich’s form 4 insider trades.

Insider Ownership Summary of Tom Frohlich

Ticker Comapny Transaction Date Type of Owner
ADRO Aduro Biotech Inc 2020-10-05 Chief Business Officer
KDNY Chinook Therapeutics Inc 2023-02-10 Chief Business Officer

Tom Frohlich Latest Holdings Summary

Tom Frohlich currently owns a total of 1 stock. Tom Frohlich owns 150,777 shares of Chinook Therapeutics Inc (KDNY) as of February 10, 2023, with a value of $6 Million.

Latest Holdings of Tom Frohlich

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KDNY Chinook Therapeutics Inc 2023-02-10 150,777 40.39 6,089,883

Holding Weightings of Tom Frohlich


Tom Frohlich Form 4 Trading Tracker

According to the SEC Form 4 filings, Tom Frohlich has made a total of 9 transactions in Chinook Therapeutics Inc (KDNY) over the past 5 years, including 0 buys and 9 sells. The most-recent trade in Chinook Therapeutics Inc is the sale of 3,700 shares on February 10, 2023, which brought Tom Frohlich around $87,875.

Insider Trading History of Tom Frohlich

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tom Frohlich Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Tom Frohlich Ownership Network

Ownership Network List of Tom Frohlich

No Data

Ownership Network Relation of Tom Frohlich


Tom Frohlich Owned Company Details

What does Aduro Biotech Inc do?

Who are the key executives at Aduro Biotech Inc?

Tom Frohlich is the Chief Business Officer of Aduro Biotech Inc. Other key executives at Aduro Biotech Inc include director & President & CEO Eric Dobmeier , 10 percent owner Versant Voyageurs I, L.p. , and 10 percent owner Versant Voyageurs I Parallel, L.p. .

Aduro Biotech Inc (ADRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aduro Biotech Inc Insider Transactions

No Available Data

Tom Frohlich Mailing Address

Above is the net worth, insider trading, and ownership report for Tom Frohlich. You might contact Tom Frohlich via mailing address: C/o Chinook Therapeutics U.s., Inc., 1600 Fairview Ave. E., Seattle Wa 98102.

Discussions on Tom Frohlich

No discussions yet.